Catalyst Pharmaceuticals Announces Settlement of FIRDAPSE® (amifampridine) Patent Litigation with Lupin Pharmaceuticals
CTLPAs Part of the Settlement, Lupin Receives a License to Market Generic FIRDAPSE Beginning in February 2035
As Part of the Settlement, Lupin Receives a License to Market Generic FIRDAPSE Beginning in February 2035
CTLP Stock Alert: Halper Sadeh LLC Is Investigating Whether the Sale of Cantaloupe, Inc. Is Fair to Shareholders
CTLPNEW YORK--(BUSINESS WIRE)--Halper Sadeh LLC, an investor rights law firm, is investigating whether the sale of Cantaloupe, Inc. (NASDAQ: CTLP) to 365 Retail Markets, LLC for $11.20 per share in cash is fair to Cantaloupe shareholders. Halper Sadeh encourages Cantaloupe shareholders to click here to learn more about their legal rights and options or contact Daniel Sadeh or Zachary Halper at (212) 763-0060 or sadeh@halpersadeh.com or zhalper@halpersadeh.com. The investigation concerns whether Can
Shareholder Alert: The Ademi Firm Investigates Whether Cantaloupe, Inc. Is Obtaining a Fair Price for Its Public Shareholders
CTLPMILWAUKEE--(BUSINESS WIRE)--The Ademi Firm is investigating Cantaloupe (NASDAQ: CTLP) for possible breaches of fiduciary duty and other violations of law in its transaction with 365 Retail Markets. Click here to learn how to join our investigation and obtain additional information or contact us at gademi@ademilaw.com or toll-free: 866-264-3995. There is no cost or obligation to you. In the cash transaction, shareholders of Cantaloupe will receive $11.20 per share, with an equity value of approx
Cantaloupe, Inc. Enters into Definitive Agreement to Be Acquired by 365 Retail Markets
CTLPMALVERN, Pa. & TROY, Mich.--(BUSINESS WIRE)--Cantaloupe, Inc. (NASDAQ: CTLP) (Cantaloupe”), a global technology leader offering end-to-end technology solutions for self-service commerce, today announced it has entered into a definitive agreement to be acquired by 365 Retail Markets, LLC (365), a leading innovator in unattended retail technologies, in an all-cash transaction with an equity value of approximately $848 million. 365 is a portfolio company of Providence Equity Partners L.L.C. (“P
Watching Cantaloupe; Shares Spike Higher, Traders Circulate Unconfirmed Report That The Company Has Seen Multiple Takeover Bids As Final Deal Nears
CTLPBarrington Research Maintains Outperform on Cantaloupe, Maintains $14 Price Target
CTLPCantaloupe Q3 Adj. EPS $0.09 Misses $0.10 Estimate, Sales $75.43M Miss $79.83M Estimate
CTLPThe Analyst Verdict: Cantaloupe In The Eyes Of 5 Experts
CTLPBarrington Research Maintains Outperform on Cantaloupe, Maintains $14 Price Target
CTLPThe Analyst Verdict: Cantaloupe In The Eyes Of 4 Experts
CTLPBenchmark Maintains Buy on Cantaloupe, Raises Price Target to $13
CTLPCantaloupe Shares Resumed Trade
CTLPCantaloupe Working With Bankers At JPMorgan Chase To Explore Options, Including Sale
CTLPCantaloupe Shares Halted On Circuit Breaker To The Upside, Stock Now Up 9.76%
CTLPBarrington Research Maintains Outperform on Cantaloupe, Raises Price Target to $14
CTLPBarrington Research Maintains Outperform on Cantaloupe, Maintains $10 Price Target
CTLPUPDATE: Cantaloupe Q4 Adj. EPS $(0.01), Inline
CTLPCantaloupe, Inc. Announces Ravi Venkatesan Appointed Chief Executive Officer
CTLPCantaloupe Sees FY23 Revenue $225M-$235M Vs $229.32M Est., Adj. EBITDA $12M-$17M
CTLPCantaloupe Q4 EPS $(0.03) Misses $(0.01) Estimate, Sales $58.03M Beat $56.34M Estimate
CTLP